Showing 1 - 9 results of 9 for search 'Zhong‐Jun Xia', query time: 0.04s Refine Results
  1. 1
    IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma

    IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma by Liang Wang, Xi-wen Bi, Yu-jia Zhu, Ying-zhi He, Qiu-yu Lai, Zhong-jun Xia, Qing-qing Cai

    Published 2018-10-01
    Get full text
    Article
  2. 2
    PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma

    PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma by Xi-wen Bi, Hua Wang, Wen-wen Zhang, Jing-hua Wang, Wen-jian Liu, Zhong-jun Xia, Hui-qiang Huang, Wen-qi Jiang, Yu-jing Zhang, Liang Wang

    Published 2016-10-01
    Get full text
    Article
  3. 3
    Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.

    Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes. by Ya-Jun Li, Wen-Qi Jiang, Hui-Lan Rao, Jia-Jia Huang, Yi Xia, Hui-Qiang Huang, Tong-Yu Lin, Zhong-Jun Xia, Su Li, Zhi-Ming Li

    Published 2012-01-01
    Get full text
    Article
  4. 4
    New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

    New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study by Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, Zhong-Jun Xia

    Published 2016-09-01
    Get full text
    Article
  5. 5
    A TNM Staging System for Nasal NK/T-Cell Lymphoma.

    A TNM Staging System for Nasal NK/T-Cell Lymphoma. by Zheng Yan, Hui-qiang Huang, Xiao-xiao Wang, Yan Gao, Yu-jing Zhang, Bing Bai, Wei Zhao, Wen-qi Jiang, Zhi-ming Li, Zhong-jun Xia, Su-xia Lin, Chuan-miao Xie

    Published 2015-01-01
    Get full text
    Article
  6. 6
    Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.

    Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type. by Ya-Jun Li, Zhi-Ming Li, Yi Xia, Jia-Jia Huang, Hui-Qiang Huang, Zhong-Jun Xia, Tong-Yu Lin, Su Li, Xiu-Yu Cai, Zhi-Jun Wu-Xiao, Wen-Qi Jiang

    Published 2013-01-01
    Get full text
    Article
  7. 7
    BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

    BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma by Xiao‐Peng Tian, Jun Cai, Shu‐Yun Ma, Yu Fang, Hui‐Qiang Huang, Tong‐Yu Lin, Hui‐Lan Rao, Mei Li, Zhong‐Jun Xia, Tie‐Bang Kang, Dan Xie, Qing‐Qing Cai

    Published 2020-06-01
    Get full text
    Article
  8. 8
    P949: COMBINATION GA AND MPR VULNERABILITY SCORING TOOLS EFFECTIVELY IMPROVE THE ABILITY TO IDENTIFY THE FRAIL ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

    P949: COMBINATION GA AND MPR VULNERABILITY SCORING TOOLS EFFECTIVELY IMPROVE THE ABILITY TO IDENTIFY THE FRAIL ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA by Minqiu Lu, Liu Peng, Junling Zhuang, Mei Zhang, Zhong-Jun Xia, Zhenling LI, Hongmei Jing, Fei Dong, Wen-Ming Chen, Yin Wu, Hebing Zhou, Yu-Ping Gong, Rong Fu, Wen-Rong Huang, Bin Chu, Yutong Wang, Yong-Qing Zhang, Sun Kai, LI Bao

    Published 2023-08-01
    Get full text
    Article
  9. 9
    Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter studyResearch in context

    Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter studyResearch in context by Li Bao, Yu-Tong Wang, Peng Liu, Min-Qiu Lu, Jun-Ling Zhuang, Mei Zhang, Zhong-Jun Xia, Zhen-Ling Li, Ying Yang, Zhen-Yu Yan, Hong-Mei Jing, Fei Dong, Wen-Ming Chen, Yin Wu, He-Bing Zhou, Rong Fu, Yu-Ping Gong, Wen-Rong Huang, Yong-Qing Zhang

    Published 2024-02-01
    Get full text
    Article

Search Tools: